Transient Fcho1/2⋅Eps15/R⋅AP-2 Nanoclusters Prime the AP-2 Clathrin Adaptor for Cargo Binding  by Ma, Li et al.
Article
Transient Fcho1/2,Eps15/R,AP-2 Nanoclusters
Prime the AP-2 Clathrin Adaptor for Cargo BindingGraphical AbstractHighlightsd The endocytic pioneer protein Eps15 engages AP-2 and
Fcho1/2 noncompetitively
d Structural analysis shows arrayed DPFmotif triad in Eps15 for
Fcho1/2 mHD binding
d DPF-based codes direct transient Fcho1/2,Eps15/R,AP-2
ternary complex formation
d In ternary complex, Fcho1 interdomain linker primes AP-2 for
cargo captureMa et al., 2016, Developmental Cell 37, 428–443
June 6, 2016 ª 2016 The Authors. Published by Elsevier Inc.
http://dx.doi.org/10.1016/j.devcel.2016.05.003Authors
Li Ma, Perunthottathu K. Umasankar,
Antoni G.Wrobel, ..., SimonC.Watkins,
David J. Owen, Linton M. Traub
Correspondence
traub@pitt.edu
In Brief
How clathrin-coated vesicles initiate at
the plasma membrane is uncertain. Ma
et al. show through structural and
biochemical analyses that a three-way
interaction between early-arriving
endocytic factors Eps15/R and Fcho1/2,
and the adaptor AP-2, promotes
membrane deposition of AP-2 in open
conformation for sustained clathrin-coat
assembly and cargo loading.Accession Numbers
5JP2
Developmental Cell
ArticleTransient Fcho1/2,Eps15/R,AP-2 Nanoclusters
Prime the AP-2 Clathrin Adaptor for Cargo Binding
Li Ma,1,3 Perunthottathu K. Umasankar,1,3 Antoni G. Wrobel,2,3 Anastasia Lymar,1 Airlie J. McCoy,2 Sachin S. Holkar,1
Anupma Jha,1 Tirthadipa Pradhan-Sundd,1 Simon C. Watkins,1 David J. Owen,2 and Linton M. Traub1,*
1Department of Cell Biology, University of Pittsburgh School of Medicine, 3500 Terrace Street, S312 BST, Pittsburgh, PA 15261, USA
2Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK
3Co-first author
*Correspondence: traub@pitt.edu
http://dx.doi.org/10.1016/j.devcel.2016.05.003SUMMARY
Clathrin-coated vesicles form by rapid assembly of
discrete coat constituents into a cargo-sorting lat-
tice. How the sequential phases of coat construction
are choreographed is unclear, but transient protein-
protein interactions mediated by short interaction
motifs are pivotal. We show that arrayed Asp-Pro-
Phe (DPF) motifs within the early-arriving endocytic
pioneers Eps15/R are differentially decoded by other
endocytic pioneers Fcho1/2 and AP-2. The structure
of an Eps15/R,Fcho1 m-homology domain complex
reveals a spacing-dependent DPF triad, bound in a
mechanistically distinct way from the mode of single
DPF binding to AP-2. Using cells lacking FCHO1/2
and with Eps15 sequestered from the plasma mem-
brane, we establish that without these two endocytic
pioneers, AP-2 assemblies are fleeting and endocy-
tosis stalls. Thus, distinct DPF-based codes within
the unstructured Eps15/R C terminus direct the as-
sembly of temporary Fcho1/2,Eps15/R,AP-2 ternary
complexes to facilitate conformational activation of
AP-2 by the Fcho1/2 interdomain linker to promote
AP-2 cargo engagement.
INTRODUCTION
The minute-to-minute protein composition of the eukaryotic
plasma membrane is managed by clathrin-mediated endocy-
tosis (CME) (Bitsikas et al., 2014). Rapid internalization occurs
at specialized zones called clathrin-coated structures (CCSs),
where signal-dependent cargo packaging is handled by the het-
erotetrameric AP-2 adaptor complex with an attendant set of
clathrin-associated sorting proteins (CLASPs) (Reider and
Wendland, 2011; Traub, 2009). As new CCSs initiate, a subset
of coat machinery congregates first, priming the plasma mem-
brane for effective transport vesicle production. These early-
arriving—pioneer—proteins include AP-2 and clathrin, the
principal structural units of surface-derived CCSs, as well as
Eps15/R (epidermal growth factor pathway substrate 15/Eps15
related) and Fcho1/2 (Fer/CIP4 homology domain only protein
1 or 2) (Taylor et al., 2011). The pioneer module of endocytic pro-428 Developmental Cell 37, 428–443, June 6, 2016 ª 2016 The Autho
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these factors depends on physical connections with the orga-
nizing plasma membrane lipid phosphatidylinositol 4,5-bisphos-
phate (PtdIns(4,5)P2) (Antonescu et al., 2011; Schifferer et al.,
2015; Zoncu et al., 2007) and on direct connections among
one another, typically mediated by short linear peptide interac-
tion motifs (McMahon and Boucrot, 2011; Traub, 2009).
The lack of a tightly coupled energy input suggests that arrival
of AP-2, pioneers, and CLASPs at the plasma membrane is
a stochastic phenomenon (Ehrlich et al., 2004; Godlee and
Kaksonen, 2013; Larson et al., 2014), in part underpinning the
variability in the precise location of CCS initiation. Given the mul-
tiplicity of possible protein-protein interactions at nucleation, it is
uncertain how timely forward progression is achieved, and how
promiscuous or off-pathway associations are avoided. This
issue is critical, as the autoinhibited soluble AP-2 adaptor re-
quires allosteric activation at CCSs (Jackson et al., 2010; Kelly
et al., 2014).
Fcho1 and Fcho2 likely play a key role in local AP-2 restructur-
ing, as they are among the earliest proteins to mark a nascent
CCS (Henne et al., 2010; Taylor et al., 2011) and affect AP-2
conformation directly (Hollopeter et al., 2014; Umasankar
et al., 2014). The two paralogs contain an N-terminal crescent-
shaped, membrane-binding EFC (extended FCH) domain also
called an F-BAR domain (Henne et al., 2007). The leading EFC
domain is followed by an evolutionarily least conserved and
intrinsically disordered segment of 200 residues that associ-
ates with the AP-2 adaptor physically (Hollopeter et al., 2014;
Umasankar et al., 2012, 2014). But what makes Fchos unusual
is that the C-terminal SH3 domain typical of most EFC-domain
proteins is replaced by a m-homology domain (mHD), distantly
related in primary sequence to cargo-selective m subunits of
the heterotetrameric clathrin adaptors such as AP-2 (Reider
et al., 2009). This combination of an EFC domain with a mHD is
exclusive and phylogenetically conserved in opisthokonts. The
thus misnamed Fcho1 and Fcho2 share overall domain architec-
ture (Katoh, 2004), while the neuron-enriched Sgip1 (SH3-
domain GRB2-like [endophilin] interacting protein 1) protein
has a mHD but lacks the folded EFC domain (Uezu et al., 2007).
The mHD of all three (designated the muniscins) binds directly
to the pioneer protein Eps15 (Henne et al., 2010; Reider et al.,
2009; Uezu et al., 2007; Umasankar et al., 2012). To better
comprehend the functional consequence of inaugural protein
encounters at a clathrin assembly zone, we report three sequen-
tial stages of inquiry. First, we delineate the minimal sequencers. Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
(legend on next page)
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tract in Eps15/R necessary to bind the mHD. Next, a 2.4-A˚-reso-
lution structure of these two interaction partners provides an
atomic-level description of the bindingmechanism. Lastly, delin-
eating the structurally distinct manners in which the mHD and
AP-2 appendages bind to Asp-Pro-Phe (DPF) triplets within
Eps15/R allows us to formulate and test in vivo a concept for
pioneer-coordinated activation of AP-2 at plasma membrane
bud sites by Eps15 bringing conformationally closed AP-2 into
proximity with the Fcho interdomain linker.
RESULTS
A mHD Interaction Network
Fcho1 and Fcho2 have numerous binding partners (Henne et al.,
2010; Mulkearns and Cooper, 2012; Reider et al., 2009; Uezu
et al., 2007; Umasankar et al., 2012). The chief interaction sur-
face is the globular C-terminal mHD. This is seen as apparent
loss of coincidence of an expressed GFP-FCHO1 lacking the
mHD with endogenous AP-2- and HRB-positive surface puncta
in transfected HeLa cells (Figures S1A and S1B). Conversely, a
tandem dimer red fluorescent protein (tdRFP)-tagged FCHO1
mHD alone (residues 609–889) localizes to AP-2-marked CCSs
when transiently expressed (Figures S1C and S1D). The
FCHO1 mHD binds directly to HRB as well as to EPS15,
EPS15R, intersectin 1, DAB2, and CALM (Figure S1E) (Henne
et al., 2010; Reider et al., 2009; Umasankar et al., 2012). Amino
acid divergence between the FCHO1 and structurally related
FCHO2 (53% identity) and Sgip1 (49% identity) mHDs is paral-
leled by differences in partner protein selectivity; FCHO2 and
Sgip1 contact a subset of FCHO1 partners (Mulkearns and
Cooper, 2012; Uezu et al., 2011; Umasankar et al., 2012)
including EPS15 (Figure S1E), but only the FCHO1 mHD binds
to HRB and CALM in our assays.
The association of muniscin mHDswith EPS15 requires the un-
structured C terminus (residues 595–896) of the protein (Cupers
et al., 1997), rich in tripeptide DPF repeats. The AP-2 a
appendage binds to this general segment of EPS15 as well,
but the mode of engagement is clearly different; AP-2 binding in-
creases linearly with additional EPS15 DPFs (Benmerah et al.,
1996; Iannolo et al., 1997) but Fcho2 binding does not (Fig-
ure S1F).When EPS15 (595–896) is immobilized on excess gluta-
thione S-transferase (GST)-AP-2 a appendage, the FCHO1 mHD
can simultaneously also bind EPS15 (Figures S1G and S1H).
This suggests non-overlapping DPF targets, as ternary com-
plexes can form by synchronous binding to different regions
of the EPS15 C terminus. Further truncation/deletion analysisFigure 1. A Minimal EPS15 Interaction Motif
(A and B) GST pull-down assays with rat brain cytosol and 250 mg of GST and
separated supernatant (S, 2%) and pellet (P, 10%) fractions were stained or imm
(C) Location of DPF triplets in the EPS15 C-terminal domain, with the relative loc
EPS15, EPS15R, and DAB2 sequences corresponding to the minimal motif, box
(D) GST pull-down assay with purified FCHO1 mHD and 50 mg of either GST or G
supernatant and pellet fractions were stained or immunoblotted with an anti-FCH
(E) Representative ITC experiments with theDanio rerio (Dr) Fcho1 mHD and EPS1
EPS15 peptides. KD, reaction stoichiometry (n), and errors were calculated from
(F) Cartoon representation of GST-EPS15-FCHO1 mHD chimeras, with the spec
below.
(G) GST pull-down assay using HeLa cell lysate and 250 mg of either GST or GST
were stained or replicates immunoblotted with the indicated antibodies as in (A).
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of EPS15 sufficient for engaging Fcho1/2 (Figures 1A–1C).
FCHO1 mHD binding to EPS15 (615–636) is dose dependent
and direct (Figure 1D). This EPS15 tract contains three closely
spaced DPF repeats (and a leading DFF triplet) highly conserved
in chordates, and is additionally present in EPS15R (Figure 1C).
The distal region (629DPFKDDPF) of the EPS15 mHD-binding
element is nearly identical to a small portion of the CLASP
DAB2 (Figures S1 and 1C) that is needed for a direct association
with Fcho2 (Henne et al., 2010; Mulkearns and Cooper, 2012;
Umasankar et al., 2012). Yet EPS15 and EPS15R bind the mHD
with higher apparent affinity than DAB2 (see Figure 3F), suggest-
ing the participation of the first of the three tandem DPFs, which
is not found in DAB2 (Figure 1C) (Mulkearns and Cooper, 2012).
Dissecting the DPF-Based EPS15 mHD-Binding
Sequence
The role of the proximal half of the mapped DPF tract on mHD
engagement is highlighted by the substantially reduced
apparent affinity of cytosolic Fcho2 for the GST-EPS15 fusion
protein when either residues 615–625 (TNLDFFQSDPF) are
removed (Figure 1A) or a 623DPF/APA mutation is introduced
into the longer 615–636 form (Figure 1B). No binding of four short
peptides encompassing only one or two DPFs between EPS15
residues 616 and 632 is detectable by isothermal titration
calorimetry (ITC) (Figure 1E). In agreement, artificially fusing por-
tions of EPS15 directly to the N terminus of the FCHO1 mHD
(Figure 1F) affects free partner binding, presumably through in-
tramolecular competition. Fusing EPS15 residues 626–637
(DEPS15; containing only DPFX2DPF), while not interfering effec-
tively with EPS15/R or intersectin 1 binding, prohibits the
engagement of the weaker-binding proteins, including DAB2
(Figure 1G). By contrast, linking EPS15 residues 615–637 (with
DFF and DPFX3DPFX2DPF) essentially eliminates all partner
binding. A 623DPF/APA substitution in the full (residues 615–
637) tandem fusion diminishes EPS15/R and intersectin binding
more efficiently than does the short fusion (residues 626–637).
This again implicates the proximal section of the EPS15
sequence in higher-affinity binding. Neither HRB nor CALM
have related DPFX2DPF motifs within the unstructured polypep-
tide regions, but are Phe rich, suggesting that the weaker affinity
of these FCHO1 mHD partners likely reflects use of variant but
related interaction motif(s).
An ectopic yet experimentally tractable manifestation of mHD
partner engagement occurs in cultured cells in the context of
a customized membrane-anchored Tac-FCHO1 mHD fusioneither 50 or 250 mg of the indicated GST-EPS15 fusion proteins. SDS-PAGE-
unoblotted with antibodies against Fcho2.
ation of the various fragments tested below. Alignment of Homo sapiens (Hs)
ed with red for identity and pink for similarity.
ST-mHD fusion protein in the presence of carrier BSA. SDS-PAGE-separated
O1 monoclonal antibody.
5 616–638 peptide or theHs FCHO1 mHD titrated with the 616–638 or indicated
a minimum of four runs.
ific EPS15 sequence for each variant preceding the GlyProSer spacer shown
-mHD fusion proteins as indicated. Separated supernatant and pellet fractions
(legend on next page)
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protein (Umasankar et al., 2014). Transmembrane Tac, the a
chain of the interleukin-2 receptor also termed CD25, normally
progresses through the biosynthetic pathway before residing
at the plasma membrane (Humphrey et al., 1993). When overex-
pressed, a newly synthesized pool of Tac is typically seen in the
Golgi en route to the surface. In Tac-mHD-, but not Tac-express-
ing cells, endogenous EPS15 relocates prominently to the juxta-
nuclear Golgi region where the cytosol-oriented mHD is highly
concentrated (Figures 2A and 2B). This Tac-mHD can act as a
near-quantitative sink for endogenous EPS15 in highly express-
ing cells, depleting EPS15 from CCSs (Figures 2A and 2C). The
short DPF tract between EPS15 residues 615 and 636 promotes
most effective translocation of a transfected tdRFP-full-length
EPS15 onto Tac-mHD-rich membranes in the Golgi region (Fig-
ures 2C–2E). Similar ectopic concentration of the RFP-tagged
full-length EPS15 does not occur upon co-transfection with
Tac alone (although a pool of Tac also concentrates in the Golgi
area) and is considerably reduced upon internal deletion of res-
idues 615–636 within the tdRFP-EPS15 reporter (Figures 2D and
2E). Comparing the intracellular positioning of transfected
tdRFP-EPS15 that is truncated after residue 636 with the endog-
enous EPS15 shows the atypical deposition of both proteins at
Tac-mHD-positive organelles within transfected cells (Figure 2F).
Further C-terminal truncation of tdRFP-tagged EPS15 at residue
615 produces little clustering in the juxtanuclear area, despite
redistribution of endogenous EPS15 by ectopic Tac-mHD in the
same cells (Figure 2G). Altogether, the results emphasize the
key contribution of the mapped EPS15 DPF stretch to mHD
engagement intracellularly, and suggest that these interactions
play a key role in clustering these EFC-domain proteins at cla-
thrin buds.
Molecular Architecture of the mHD Interaction Interface
To locate the molecular surface of the mHD that physically con-
tacts Eps15, we attempted crystallization of mHDs from several
species, both alone and in complex with EPS15 peptides.
When all efforts failed, the tailored chimeras (Figure 1F) were
evaluated. A fusion of EPS15 (designated ET615-EG637) to the
zebrafish Fcho1 mHD (residues 867–1,152) with a GAGA spacer
crystallized and diffracted to 2.4 A˚. The structure was solved by
single-wavelength anomalous dispersion using an Xe derivative
(TableS1). In the final structure, excellent-quality electron density
is visible for residues EF620-EG637 of EPS15 (Figure S2A) and
P874-L1152 of the mHD. There is no evidence of the spacer res-
idues separating the EPS15 and mHD sections, but distance con-
straints make it highly likely that the interaction is intramolecular.
Like other m subunits, the Fcho1 mHD contains 18 b strands ar-
ranged as two intercalated b-sandwich subdomains, the fold be-Figure 2. The EPS15 mHD Interaction Motif In Vivo
(A and B) Representative single confocal optical sections of basal surface of HeL
Fixed cells were stained with anti-Tac or anti-EPS15 antibodies. Enlarged color
localized Tac and EPS15 (arrows) are indicated. Scale bar, 10 mm.
(C–E0) Typical basal confocal sections of fixed HeLa cells double transfected wi
against Tac and GPP130 as indicated (C0–E0). Corresponding medial optical sectio
of Tac protein. Scale bar, 10 mm.
(F and G) Representative medial confocal optical sections of HeLa cells transiently
as indicated after fixation and staining with anti-Tac and anti-Eps15 antibodies. E
antibody raised against the extreme C terminus of the protein, which is truncate
432 Developmental Cell 37, 428–443, June 6, 2016ing comparable with the orthologous Saccharomyces cerevisiae
Syp1p mHD (Reider et al., 2009) and m1–m4 (Figures S2A–S2F).
Yet the Fcho1 mHD also contains three additional a helices in
subdomain A (Figures S2A–S2C), and the concave face of the
Fcho1 mHD is considerably more curved than other mHDs.
The EPS15 segment binds in a spiral trough that runs halfway
around the long axis of subdomain A, with the Fcho mHD-
unique a helices forming a considerable part of the trough (Fig-
ure 3A). The trough is lined with conserved largely hydrophobic
residues, and significant contacts with the protein are only
through the three DPF motif side chains of the sequence
623DPFVGSDPFKDDPF (Figures 3A–3D); the interaction buries
1,640 A˚2 of solvent-accessible area. The electron density indi-
cates well-ordered DPFs; the first two adopt type I tight turn con-
formations (Figures 3D and S2A) stabilized by intramolecular H
bonding between the Asp residue side chains and the backbone
amide of the +2-position Phe residues. In the last DPF, the side
chain of ED634 additionally forms a salt bridge with R1133. In this
way, the ordered triple-DPF motif projects a stabilized contig-
uous hydrophobic surface into the trough with the Pro residues
orienting the Phe side chains to closely match the complemen-
tary mHD interaction surface (Figure 3D). Thus the structure
strongly suggests that the short tri- (VGS) or di- (KD) residue
spacing between tandem DPFs is important to allow three to
simultaneously dock onto a single Fcho1 subdomain A with a
1:1 stoichiometry. The weakest EPS15 peptide electron density
is around G627, reflecting inherent mobility of non-chiral G resi-
dues and suggesting it may be a flexible pivot. Our interpretation
is that, depending on the binding partner, the trough can be
either fully or partially occupied. The site is therefore ‘‘plastic,’’
with partners evolving appropriate strength interactions by filling
different portions of the extended trough. This contrasts with
other interactions in vesicle coat formationwhereby a small bind-
ing cavity on a folded protein accommodates a single small
motif, and variations in affinity occur through different motif
copy numbers. Below, we use the human FCHO1 mHD to confirm
the binding mechanism (substantiating that the interaction sur-
face in the structure is not an artifact of using the chimera); ze-
brafish and human Fcho1 mHDs are 56% identical and bind
EPS15 with similar KDs (Figure 1), but FCHO1 mHD has better
biochemical behavior. Residue numbers that follow are thus for
the equivalent human mHD (Figure S2B).
Structure-guided mutation of FCHO1 mHD residues located
near the N-terminal region of the docked EPS15 peptide verifies
the role of the binding trough. A number of single substitutions in
this general area each have only slightly decreased binding prop-
erties (Figures 3 and S3), indicating that multiple alterations to
the extended contact interface upon the mHD are necessary toa SS6 cells transfected with either Tac-FCHO1 mHD (A) or Tac (B) as indicated.
-separated regions corresponding to the boxed areas are shown and Golgi-
th the indicated Tac and tdRFP-EPS15 plasmids and stained with antibodies
ns of the boxed regions are shown (C–E) indicating the Golgi pool (arrowheads)
transfected with Tac-FCHO1 mHD and either tdRFP-EPS15 (1–636) or (1–614)
nlargements of boxes as in (A). Note that the anti-Eps15 is a peptide-specific
d in the two tagged exogenous proteins. Scale bar, 10 mm.
Figure 3. A Major Interaction Surface on Fcho1 mHD Subdomain A
(A–C) Combination ribbon and molecular surface representation of the concave face of zebrafish Fcho1 mHD subdomain A showing the EPS15 binding trough.
(A) The b strands involved and projecting mHD contact residues (light orange), determined by the PISA server. Selected side chains mutated are indicated (dark
orange) with the corresponding residue number in the FCHO1 mHD indicated in orange type. (B) View of the tandem DFPmotifs (stick representation with carbon
mauve, nitrogen blue, and oxygen atoms red) bound to the mHD. EF636 is shown in a dual conformation with mHD W833 also in dual conformation to permit
flipping of EF636. (C) ENDscript 2 (Robert and Gouet, 2014) computed phylogenetic surface conservation between muniscin mHDs using the TrEMBL (opis-
thokonta) database for sequence alignments. Conservation graded in shades from invariant (red) to unrelated (white) projected onto the solvent-accessible
molecular surface of the Fcho1 mHD. The surface conservation reveals a patch (cyan oval) of invariant and highly conserved residues at the binding site on
subdomain A, while there is a rather discombobulated patchwork pattern of conservation over the convex face.
(D) The bound DPF tract showing the spatial arrangement of the aromatic Phe and Pro side chains packing into the mHD trough.
(E) Pull-down assay utilizing HeLa cell lysate and 250 mg of GST, GST-FCHO1 (orange box), or GST-FCHO2 (pink box) mHD, or the indicated mutant. Stained gel
and replicate blots were probed with the indicated antibodies. Position of bound partner protein (arrowheads) is indicated.
(F) Pull-down assay with HeLa cell lysate and the indicated amount of GST, GST-FCHO1 mHD, or K877E + R879Amutant immobilized on glutathione-Sepharose.
(G) Representative ITC experiments of wild-type FCHO1 or color-coded mutant mHDs binding to an EPS15 616–638 peptide.
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effectively disrupt binding. For compound double mutants in this
part of subdomain A, the most detrimental is a K877E + R879A
substitution at the outer rim of the trough. Here, association of
all weak binding partners is abolished and the recovery of the
strongest binding partner (native EPS15 dimer/tetramer) is
reduced at least 25-fold (Figures 3E and 3F). ITC (Figure 3G) re-
veals binding to EPS15 peptide (616–638) is reduced to unde-
tectable levels (KD > 300 mM versus 2.7 mM for wild-type mHD).
Simultaneous alteration of the nearby conserved residues
N735A + R740A has a different and weaker inhibitory effect: du-
rable EPS15/R binding still persists, but HRB and CALM associ-
ations are lost (Figure 3E).
Subdomain Amutations in the a-helical region located close to
the second DPFX2DPF repeat again affect binding (Figures S3A
and S3B). Besides a Y733A substitution, which is insoluble (all
others were correctly folded judged by gel filtration and circular
dichroism), a P627D + A629E switch is most detrimental to all
cytosolic binding partners in pull-down assays. ITC using the
EPS15 (616–638) peptide shows essentially no (KD > 300 mM)
binding for the A629E or P627D + A629E substitutions (Fig-
ure S3C). Other nearby substitutions, such as S732D and
R872A + S874G, produce weaker inhibitory effects, most
conspicuously on EPS15/R. In sum, the effects of the various
structure-guided substitutions show that different partners
occupy a common extended mHD surface but display different
binding affinities, likely related to occupancy of different portions
of the trough, and that Eps15 engagement involves higher-order
decoding of adjacent DPF motifs filling the trough.
Several binding-trough amino acids differ in the Fcho2 and
Sgip1 mHDs; the tripeptide 633TXY in strand b1 at the base of
the trough is [TS]X[ST] in Fcho2 and Sgip1 orthologs (Fig-
ure S3D). Yet the noted selectivity between FCHO1 and
FCHO2/Sgip1 for HRB and CALM binding (Figure S1E) cannot
be solely attributed to this Y635T/S dichotomy. An FCHO1
Y635S alteration does not prevent binding of either HRB or
CALM (Figure S3E). The adjacent T633Y substitution produces
a modest gain-of-function effect for the weaker partners, HRB
andCALM. These results illustrate that varied mHDpartnermotifs
have evolved not an optimal but rather an acceptable fit, given
the temporal and spatial requirements of these interactions
in vivo.
The muniscin mHD, AP m subunits, and d-COP (Suckling et al.,
2015) mHD all evolved from the TCUP subunit of the ancestral
TSET/TPLATE sorting complex (Gadeyne et al., 2014; Hirst
et al., 2014). Our work shows that in addition to conservation
of the overall architectural fold, the general locale of the main
peptide contact surfaces on the concave face of subdomain A
is broadly similar but the molecular mechanism of peptide bind-
ing is different (Figure S2); the muniscin interaction is more
expansive and is not of a b-augmentation type.
mHD Interactions In Vivo
Unfortunately the functional role of the mHD cannot be explored
simply in cells by direct deletion or mutation of full-length pro-
teins, because forced overexpression of the Fcho1/2 EFC+ linker
augments CME by promoting AP-2 opening (Hollopeter et al.,
2014; Umasankar et al., 2014). The unstructured interdomain
linkers of Fcho1, Fcho2, and Sgip1 all bind physically to the het-
erotetrameric AP-2 adaptor core, and this biochemical activity is434 Developmental Cell 37, 428–443, June 6, 2016correlated with improved AP-2-dependent cargo uptake (Hollo-
peter et al., 2014; Umasankar et al., 2014). When expressed
ectopically in HeLa cells as a Tac-fusion protein, the FCHO1
linker alone improves transferrin internalization (Umasankar
et al., 2014). Paradoxically, these results make it appear superfi-
cially as if the mHD is functionally unnecessary. However, of all
the pioneers the muniscins are present as limiting components
(Figure S1I); overexpression studies evade this level of regulation
by copy number. As outlined below, we hypothesize that it is pre-
cisely this low abundance of FCHO1/2 that makes the concerted
transactions between the mHD and the interdomain linker phys-
iologically relevant.
Unlike the Tac-mHD (Figure S4A), a K877E + R879A mutation
prohibits overexpressed Tac-mHD from abnormally clustering
EPS15 in the juxtanuclear region in transfected HeLa cells;
EPS15 localization is much like control Tac-transfected cells
(Figures S4B and S4C). Of all the cytosolic proteins that bind
to the mHD in pulldowns, only EPS15 and HRB prominently
change intracellular placement in the presence of wild-type
Tac-mHD, although some HRB surface puncta remain. Intersec-
tin 1, DAB2, and CALM do not show pronounced changes in
plasma membrane surface deposition compared with cells ex-
pressing Tac only (Figures S4A–S4F). This could reflect the
densely redundant protein-protein and protein-lipid interaction
networks these other mHD partner CLASPs display at surface
CCSs (Figure S1I).
Ectopic mHD Expression in FCHO1/2-Null Cells
To examine this further, we overexpressed Tac-mHD in HeLa
clone 1.E cells. This genome-edited clone is functionally
FCHO1+2 null and displays clustered, enlarged surface CCSs
at steady state (Umasankar et al., 2014). In 1.E cells, ectopic
Tac-mHD again causes strong mislocalization of EPS15 and
HRB (Figure 4A). Yet intersectin 1, DAB2, and CALM still do
not mass prominently in the Golgi region when Tac-mHD is ex-
pressed (Figures 4B–4E). Regardless, the ectopic Tac-mHD strik-
ingly alters endocytic CCS appearance in themuniscin-null cells;
different to adjacent non-transfected 1.E cells, the Tac-mHD pro-
ducers (identified by Tac staining and/or Golgi mislocalized
EPS15 or HRB) exhibit small, dim, and generally dispersed
AP-2-positive structures (Figure 4C). AP-2, intersectin 1, DAB2,
CALM, and HRB, which co-populate most enlarged CCSs in
parental 1.E cells, spatially segregate into non-overlapping spots
when wild-type Tac-mHD is present (Figures 4B–4E). The scat-
tered appearance of these coat components in the presence of
membrane-anchored mHD resembles the population of smallest
CCSs, increased in frequency in parental 1.E cells (Umasankar
et al., 2014). Analogous alterations to AP-2-positive puncta
occur when overexpressed FCHO1 mHD is instead targeted to
endosomes by fusion to paired FYVE domains (Figure 4F). Again,
massive intracellular EPS15 sequestration occurs and surface
AP-2 puncta diminish in size and intensity. The mHD of Sgip1,
which does not interact directly with either HRB or CALM (Fig-
ure S1E), also causes a reorganization of surface AP-2 when
overexpressed in HeLa 1.E cells as a Tac-fusion protein (Figures
S5A–S5F). Under our experimental conditions, we cannot
completely exclude that the ectopic Tac-mHD we use to move
EPS15 and EPS15R onto intracellular membranes does not alter
subtly the precise location or dynamics of the cytosolic pools of
Figure 4. Altered CCSs in Tac-mHD-Transfected HeLa 1.E Cells
(A–E) Deconvolved maximal projections of HeLa clone 1.E cells transfected with Tac-mHD and stained with the indicated antibody combinations. Transfected
cells (blue outline), misrecruited juxtanuclear EPS15 and/or HRB (arrowheads), and altered pioneer/CLASP distributions (yellow arrows) are indicated.
Sequestration is dose dependent; residual HRB-positive enlarged CCSs (white arrow) in a low Tac-mHD expresser (asterisk) are indicated in (A). Scale bar, 10 mm.
(F–F00) Representative deconvolved maximal projection of GFP-FYVE-mHD transfected (green outline) HeLa 1.E cells stained with the indicated antibodies. Scale
bar, 10 mm.
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other mHD-binding partners, including DAB2, HRB, and CALM.
But even were this the case, it still attests to the fundamental
importance of the mHD interaction surface we delineate here in
coordinating protein-protein contacts at nascent bud sites.
That EPS15 misrecruitment is not accompanied by large-scale
intracellular deposition of AP-2 also reinforces that the different
affinities that mHDs and AP-2 appendages display for DPFs
also manifest in vivo, and makes plain the requirement for an
appropriate acceptor membrane to promote AP-2 switching
from the cytosolic closed state to the membrane-docked,
cargo-binding-competent open state.
The phenotypic effect of combined siRNA silencing of EPS15
and EPS15R transcripts in clone 1.E cells is also consistent with
a direct role for EPS15/R in stabilizing nascent AP-2 assemblies
at the cell surface; in cells with strongly diminished EPS15 there
is a shift in the distribution of AP-2 puncta to the smallest-size
populations (Figures S5G–S5L). Our results thus suggest that
in the combined absence of muniscins and EPS15/R, a lack of
coat consolidation/stabilization follows random clathrin-coat
component encounters with the plasma membrane, accounting
for the small dim puncta. Because neither intersectin, CALM,
DAB2, nor AP-2 accumulates on concentrated intracellular
Tac-mHD, this tactic to selectively mislocalize EPS15 (and
HRB) in muniscin-null cells allows further functional dissection
of the EPS15/R,mHD interaction in CME using transferrin uptake
assays and total internal reflection fluorescence microscopy
(TIRFM).
Impact of mHD Interactions on CME
First, we assessed ligand uptake. On a 2-min pulse, fluores-
cently labeled transferrin clusters at, and is internalized from,
abnormally enlarged CCSs in parental 1.E cells. Obviously
different from this surrounding untransfected 1.E cell popula-
tion, the Tac-mHD transfected 1.E cells, which display bright
intracellular EPS15 staining and dispersed small faint plasma
membrane dots of AP-2, accumulate transferrin diffusely over
the plasma membrane, and uptake into endosomes is strongly
slowed (Figures S6A–S6A00 0), indicating defective CME. Even
after 10 min of incubation with transferrin, Tac-mHD-producing
cells with dim AP-2 spots internalize very little cargo relative to
neighboring untransfected 1.E cells with typically large CCSs
(Figures S6B–S6B00 0). Thus the fine AP-2 puncta at the surface
do not efficiently package the prototypical YXXØ-type signal
cargo protein, the transferrin receptor when FCHO1/2 and
EPS15 are limiting (i.e., depleted from the vicinity of the
plasma membrane). These results are in stark contrast to our
previous findings regarding the effect of transfecting the
same FCHO1/2-null 1.E HeLa cells with Tac fused instead to
the preceding FCHO1 interdomain linker (residues 265–609)
(Umasankar et al., 2014). This disordered segment of FCHO1
between the folded EFC domain and mHD also alters the
steady-state morphology of CCSs to small regular puncta,
but in this case they are brighter (contain more AP-2) and trans-
ferrin uptake is actually stimulated (Figures S6C–S6C00 0) as the
linker on the plasma membrane can trigger AP-2 to adopt an
open, cargo-binding conformation (Hollopeter et al., 2014;
Umasankar et al., 2014). In fact, in Caenorhabditis elegans,
numerous fcho-1-null bypass suppressor mutations in AP-2
subunits, which shift the equilibrium of AP-2 to the open state,436 Developmental Cell 37, 428–443, June 6, 2016completely negate any requirement for FCHO-1 in vivo (Hollo-
peter et al., 2014).
Definitive evidence for defective CME comes from cells pulsed
with transferrin at 37C for 2 min, surface stripped on ice, and
reheated to 37C for an additional 2 min. The peripheral trans-
ferrin-positive early endosomes abundant in surrounding un-
transfected 1.E cells are diminished in Tac-mHD-producing 1.E
cells that also exhibit altered AP-2 spots (Figures 5A and
S6D). By comparison, 1.E cells expressing Tac-mHD (K877E +
R879A) have transferrin and AP-2 staining roughly comparable
with adjacent untransfected cells (Figure 5B). In transferrin-
pulsed 1.E cells labeled for AP-2 and also for EPS15 to observe
internal sequestration of this pioneer by Tac-mHD, transferrin
uptake is sharply reduced (Figure 5C). By contrast, Tac-linker-
positive cells have a characteristic changed AP-2 arrangement,
and more numerous and medial transferrin-positive endosomes
(Figures 5D and S6D). The observed AP-2 puncta in either
Tac-mHD- or Tac-linker-producing 1.E cells are therefore func-
tionally distinct, with the explanation for the opposite outcomes
on transferrin internalization being that the Tac-mHD exerts a
dominant sequestration effect on EPS15 at intracellular mem-
branes while the Tac-linker works by gain of function on AP-2
at the plasma membrane (Umasankar et al., 2014).
The AP-2 puncta in Tac-mHD-expressing 1.E cells appear
similar to the small abortive CCSs that arise in cells expressing
AP-2 lacking the a-subunit appendage (Aguet et al., 2013), which
binds directly to single EPS15 DPFs among other ligands
(Brett et al., 2002; Praefcke et al., 2004). However, marked sur-
face transferrin accumulation shows that Tac-mHD-transfected
HeLa 1.E cells do not display compensatory CME, like cells
with endogenous Eps15 and Fcho1/2 (Aguet et al., 2013; Motley
et al., 2006). Indeed, time-resolved imaging of b2-YFP-marked
AP-2 puncta on the bottom of FCHO2-null HeLa cells
(clone #46b, Figures S7A–S7E) transfected with Tac-mHD re-
veals highly dynamic, dim, short-lived (presumably unproductive
or abortive) spots (Figures 6A and 6C), explaining the accumu-
lating transferrin at the plasma membrane. For these live-cell
studies we used the FCHO2 gene-disrupted HeLa clone #46b
cells because FCHO1 protein levels are extremely low in HeLa
cells (Hein et al., 2015; Umasankar et al., 2012) and the endocytic
phenotype and behavior of FCHO2-null and FCHO1/2-null HeLa
cells are indistinguishable (Umasankar et al., 2014). Similarly to
HeLa and clone 1.E cells, ectopic Tac-mHD redirects endoge-
nous EPS15 to a perinuclear location in the clone #46b cells (Fig-
ures S7F and S7G). The time-resolved imaging experiments
show importantly that defective diminutive AP-2 puncta occur
in living Tac-mHD-producing cells and that they display abnormal
kinetic behavior (Figures 6C and 6D). In parental #46b cells, 75%
of patch lifetimes are >108 s (median spot duration 294 s).
When expressing the Tac-mHD, the median spot duration in
these cells becomes 30 s compared with 74 s for cells ex-
pressing the Tac-linker (Figure 6D). The kinetic behavior (median
duration 75 s) and area distributions of AP-2 puncta in Tac-
linker expressing clone #46b cells closely resemble HeLa SS6
b2-YFP cells, from which the #46b cells were derived (Figures
6D–6G). Collectively these experiments show that, alone, the
Fcho mHD or Fcho linker can change the morphology, kinetic
signature, and cargo-sorting capacity of surface CCSs in
muniscin-null cells. Since the interdomain linkers of Fcho2 and
(legend on next page)
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Sgip1 also affect AP-2 complex conformation (Hollopeter et al.,
2014; Umasankar et al., 2014), our findings underscore the func-
tional adaptation and importance of sequentially arranged re-
gions of the low-abundance muniscins (Figure S1I). In cells, we
propose that the linkedmuniscin domains act on AP-2 in concert
by virtue of the protein-binding properties of the mHD; they bring
together the necessary protein machinery to switch AP-2 from
the basal closed conformational state to the open active form.
DISCUSSION
This work explores how interactions between Fcho1/2, Eps15/R,
and AP-2 contribute to CCS nucleation. While Eps15 engages
Fcho1/2 and AP-2 in fundamentally different and noncompeting
ways, both intriguingly depend on DPF triplet-based recognition
(Brett et al., 2002; Praefcke et al., 2004). Within the Eps15 un-
structured region, residues 600–650 contain seven DPF repeats
that, with limiting spacing requirements, bind Fcho1/2 as a
higher-level triple-DPF motif. AP-2 binding to distal Eps15 resi-
dues 650–740 (Benmerah et al., 1996; Iannolo et al., 1997) de-
pends on only single DPF motifs (Brett et al., 2002; Praefcke
et al., 2004). Relatively tight apparent binding is due to avidity
phenomena: multiple a appendages from independent AP-2 het-
erotetramers bind to the array of single DPFs (Praefcke et al.,
2004) on the Eps15 dimer/tetramer (Cupers et al., 1997), and is
further enhanced by the AP-2 b2 appendage also binding
Eps15, albeit through a different Phe-rich motif (Edeling et al.,
2006; Schmid et al., 2006). While this synchronous binding of
separate DPFs to individual AP-2 appendages is facilitated by
unstructured intervening peptide stretches between DPFs, strict
inter-motif intervals are unimportant. Consequently, spacing
constraints have allowed Eps15/R to separately tune DPF-bind-
ing selectivities for mHDs and AP-2 appendages (Figure 7A). The
two proteins bind independently of one another; docking of a tri-
ple-DPFmotif onto a mHD does not affect the remaining unstruc-
tured Eps15 C terminus, leaving it free to engage one or more
AP-2 adaptors. The tighter binding and slower off-rate of a tri-
ple-DPF,mHD interaction (KD y 3 mM) compared with a single
DPF,a-appendage interaction (KD  200 mM) (Olesen et al.,
2008) favors initial Fcho1/2,Eps15/R heterodimer formation
(Figure 7A). On the plasma membrane, at a forming CCS, where
clustered AP-2 is bound with low micromolar affinity and ori-
ented by PtdIns(4,5)P2, the high off-rate of a lone DPF from an
appendage is less critical; fast rebinding would occur, and since
multiple appendages can simultaneously be engaged by the
distal Eps15/R C termini of Eps15 oligomers, Fcho1/2,Eps15/
R,AP2 nanocluster formation is favored.Figure 5. Defective CME in Tac-mHD-Expressing 1.E Cells
(A–B0) HeLa clone 1.E cells transfected with either Tac-mHD (A) or the Tac-mHD (K
surface stripped on ice, and rewarmed to 37C for another 2min before fixation. Re
stained with antibodies against Tac and the AP-2 b2 subunit is indicated. Transfec
(A0) and (B0). Scale bar, 10 mm. Correlative linescan analysis at indicated locations
transfected cells indicated with a vertical cyan bar and horizontal broken cyan lin
(C–D0) Deconvolved z stack projections of 1.E cells transfectedwith either Tac-mH
and permeabilized cells were stained with antibodies against the AP-2 a subunit a
(yellow arrows) and diminished transferrin internalization contrasts the retention o
endocytosis in presence of the Tac-linker. Scale bar, 10 mm. Correlative linescan
right, with relative position of transfected cells indicated as in (A) and (B).
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In HeLa clone 1.E cells lacking muniscins, EPS15/R can direct
the assembly of stable, enlarged, long-lived CCSs with delayed
CME (Umasankar et al., 2014). Silencing of EPS15/R (Teckchan-
dani et al., 2012) or reconstitution of knocked-down AP-2 cells
with an a-appendageless AP-2 heterotetramer (Aguet et al.,
2013) similarly causes enlarged, clustered, and functionally
abnormal CCSs. We now show that without both FCHO1/2 and
EPS15/R, CCSs are short-lived and CME is further disrupted.
This information points to an interdependent three-way relation-
ship between muniscins, Eps15/R, and AP-2. So how does the
deciphered DPF code support productive CCS formation? Extin-
guishing clathrin expression in HeLa cells by RNAi blocks CME,
but has little impact on deposition of a planar AP-2, EPS15, and
CALM matrix on the plasma membrane (Hinrichsen et al., 2003;
Meyerholz et al., 2005; Motley et al., 2003). This indicates that
adaptors/CLASPs require clathrin, in all probability by clustering
CLASPs to high local density, for proper membrane deformation,
but that initial congregation of pioneers at emerging buds is
largely clathrin independent (Hinrichsen et al., 2006). By contrast,
AP-2 transcript silencing leads to diminutive CCSs (Miller et al.,
2015; Motley et al., 2003). One interpretation of this is that
AP-2 deposition at nascent assembly zones expands the devel-
oping coat by loading the interior of a pioneer-rich patch, with
open AP-2 able to engage cargo (Figure 7B). How would this
happen? AP-2, Eps15/R, and Fcho/2 differ considerably in pro-
jected copy number/cell (Hein et al., 2015) and, hence, attainable
stoichiometry at individual assembly zones (Borner et al., 2012).
When an EFC domain docks on the negatively charged plasma
membrane (Umasankar et al., 2012), Fcho1/2,Eps15/R com-
plexes (Figure 7B, step 1) could sequentially bind to (step 2)
and then deposit AP-2 adaptors in the immediate vicinity, aided
by interaction of the AP-2 a/b2-subunit trunks with plasmamem-
brane PtdIns(4,5)P2. A local but temporary DPF-mediated three-
component nanocluster would allow AP-2 to linger in the vicinity
of Fcho1/2 to advance CCS assembly by encounters with the
muniscin effector linker (step 3). This interaction leads to confor-
mational rearrangement of AP-2 to an ‘‘open’’ or active form (Hol-
lopeter et al., 2014; Umasankar et al., 2014) that facilitates cargo
engagement (step 4) and release of the AP-2 b2-subunit hinge to
promote clathrin polymerization (step 5). In this way, a large in-
crease in AP-2 dwell time at the forming CCS results.
This scenario is grounded on the observations that despite re-
taining PtdIns(4,5)P2 binding, AP-2 without an a appendage is
only weakly plasma membrane associated (Robinson, 1993);
that overexpression of an N-terminally-deleted Eps15 mutant
lacking EH domains 2 and 3 mislocalizes AP-2 and inhibits877E + R879A) mutant (B) and pulsed with transferrin (red) for 2 min at 37C,
presentative deconvolvedmaximal intensity z projection of permeabilized cells
ted cell groups are outlined, and superimposed transferrin and AP-2 shown in
in A0 and B0 (dashed vertical line) is shown on the right, with relative position of
es.
D (C) or Tac-linker (D) and similarly pulsedwith transferrin as in (A) and (B). Fixed
nd EPS15 as indicated. Tac-mHD-dependent intracellular clustering of EPS15
f EPS15 in regular AP-2-positive surface puncta (orange arrows) and enhanced
analysis at indicated locations in (C0) and (D0) (red dashed line) is shown on the
(legend on next page)
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CME (Benmerah et al., 1999; Carbone et al., 1997); and that
microinjected a appendage inhibits AP-2 deposition at CCSs
(Hinrichsen et al., 2006). As the local concentration of AP-2 in-
creases at the assembly zone, other incoming adaptors/CLASPs
such as Dab2, ARH, epsin, and CALM, because they are more
abundant (Figure S1I) (Hein et al., 2015), can outcompete
Eps15/R for appendage binding since they all also bind
PtdIns(4,5)P2, clathrin and cargo in addition to engaging AP-2
(Figure 7B). In this way, Eps15 and associated muniscins will
be displaced from the center of the nascent CCS. Eps15/R
and associated muniscins become positioned around the
growing lattice edge while bulk AP-2 concentrates in the CCS
center. Our experimental data support this hypothesis in that,
for CCSs of at least moderate size in HeLa cells, FCHO2 is
restricted to a band of globular proteinaceous material that we
visualize surrounding assembled clathrin (Figures 7C–7E), simi-
larly to Eps15 (Edeling et al., 2006; Henne et al., 2010; Tebar
et al., 1996). Proteomic analysis also supports the model,
showing that relatively little FCHO2 and EPS15/R is packaged
into budded coated vesicles (Borner et al., 2012) despite their
early appearance at beginning CCSs (Taylor et al., 2011). The
outer rim of the forming CCS will thus delimit the perimeter and
constrain productive coat polymerization to within the assembly
zone. The edge effectively also conveys assembly information
because remodeling of the clathrin patch, assembly of which is
triggered by activation of AP-2, from an initial flat to hemispher-
ical and then deeply invaginated profile at the center, requires
polymeric clathrin (Avinoam et al., 2015; Hinrichsen et al.,
2006; Miller et al., 2015; Wu et al., 2003). Finally, the proposed
working model provides an explanation for the open question
of how AP-2 can be massed at CCSs stoichiometrically
exceeding other pioneer factors, yet depends on them in part
for recruitment.
A remarkable capability of surface CCSs is to quickly produce
cargo-packed transport vesicles, often in single turnover events,
at variable locations on the plasma membrane. Our results and
others (Mulkearns and Cooper, 2012; Teckchandani et al.,
2012) reveal that although alterations in FCHO1/2:EPS15/R ra-
tios change CCS morphology and distribution, CME does not
halt under these conditions. AP-2, CALM, DAB2, and other
appendage-binding CLASPs co-cluster at enlarged CCSs in
FCHO1/2-null cells (Figure 4). Internalization is slowed but, given
time, transmembrane cargo internalizes, substantiating that
Fchos guide efficient cargo-laden vesicle production. The model
we propose also provides a mechanistic rationale for the previ-
ously unexplained demonstration of defective AP-2-dependent
cargo uptake in fcho-1 mutant C. elegans complemented with
a single-copy FCHO-1 lacking the mHD (Hollopeter et al., 2014).Figure 6. Uptake Defects in FCHO2 and EPS15 Compromised Cells
(A–B0) TIRFM analysis of HeLa clone #46b cells transfectedwith either Tac-mHD (A
(center), and a final confocal image (A0, B0) of the same area after labeling with an
line (orange) on the first TIRFM fame (left) indicates the coordinates for the kymo
kymographs are marked (dashed horizontal red lines). Scale bar, 10 mm.
(C) Time-lapse examples of local b2-YFP puncta selected from the image serie
structures in the control clone 1.E cells compared with the transfected cells. Rep
(D) Box-and-whisker (minimum-maximum) plot quantitation of computed spot dur
HeLa SS6 b2-YFP cells. Median is indicated in yellow and the number of fluores
(E–G) Enlarged gray-scale view (E) of region boxed in (B) illustrating selected exam
number of spots analyzed for each condition are indicated. Scale bars, 1 mm (E)
440 Developmental Cell 37, 428–443, June 6, 2016In sum, it is now evident that the role of the multistep (Aguet
et al., 2013) initial DPF-code-mediated Fcho1/2-Eps15-AP-2-
Dab2-Hrb-CALM interactome, the details of which we illuminate
here, is to first prime the endocytic process and then optimize
cargo packaging. As this is the principal biological imper-
ative for clathrin-coated vesicle production, the assembly of
Fcho,Eps15,AP2 nanoclusters is at the core of efficient CME.
EXPERIMENTAL PROCEDURES
Materials, Plasmids, Protein Expression, and Cell Culture
Standard techniques were used throughout. Detailed information about ap-
proaches and description of methods are presented in Supplemental Experi-
mental Procedures. All experiments reported were repeated at least three
times with similar results.
Crystallization and Structure Determination
Crystals of the EPS15-Fcho1 mHD chimera grew in hanging drops against
a reservoir of 100 mM Bis-Tris propane (pH 6.0), 200 mM sodium citrate,
22% polyethylene glycol 3350, and 10 mM DTT and were cryoprotected
in 22% glycerol before freezing. A Xe derivative was used for phasing
(Table S1).
Biochemical Assays
Pull-down assays entail mixing glutathione-Sepharose-immobilized GST-
fusion proteins with a cell extract or purified proteins, washing, and analysis
of resulting supernatant and pellet fractions. For SDS-PAGE and blots, five
timesmore of each pellet versus supernatant fractionwas loaded. ITC involves
repeated injection of EPS15 peptides into a temperature-controlled solution
of mHD utilizing a Nano ITC instrument (TA Instruments).
Endocytosis Assays
Prior to transferrin addition, HeLa cells were incubated for 60 min at 37C in a
starvation medium of DMEM supplemented with 25 mM HEPES and 0.5%
BSA of to clear receptors of apotransferrin. Fluorescently labeled Alexa Fluor
transferrin (25 mg/ml) was added in prewarmed (37C) medium and internaliza-
tion was for either 2 or 10 min at 37C. For the transferrin pulse-chase uptake
assays, starved cells were incubated with fluorescent transferrin at 37C for
2 min and then immediately chilled on ice and washed with PBS as described
by Reis et al. (2015). Surface-bound transferrin was then stripped by washing
the adherent cells three times with cold 0.2 M acetic acid and 0.2 M NaCl
(pH 2.5) on ice. Prewarmed DMEM containing 25 mM HEPES and 0.5%
BSAwas added to the stripped cells, whichwere then returned to a 37Cwater
bath for an additional 2 min before fixation.
Microscopy
Confocal imaging was on an inverted Olympus FV1000 microscope equipped
with a PlanApo N (60 3/1.42 NA) oil objective. Excitation and emission wave-
lengths were preprogrammed by the instrument running the FV10-ASW soft-
ware, and emission signals in the different channels were collected in the
sequential scan mode. Exported TIFF file images were imported into Adobe
Photoshop CS4 for minor adjustments to brightness and/or contrast. Quanti-
tation of transferrin uptake in confocal image files was performed using the
linescan application within MetaMorph (Molecular Devices). The extent of) or Tac-linker (B). The initial frame of the kymograph series (left), the kymograph
ti-Tac and fluorescent transferrin (right) are shown. A single pixel-width vertical
graph (center panel), and the relative locations of the transfected cells in the
s in (A) and (B) to detail the major differences between the long-lived large
resentative individual spot life times (arrows) are indicated.
ations from the kymographs in (A) and (B), and also compared with the parental
cent puncta analyzed/condition is indicated.
ples of the color-coded spot area bins (F) used in quantitation (G). The SD and
and 0.5 mm (F).
Figure 7. Transient Higher-Order Com-
plexes to Load Active AP-2 at Growing As-
sembly Zones
(A and B) Schematic models for edge effects on
vectorial CCS initiation. The DPF code (A) will
have consequences for the formation and stability
of Eps15,Fcho1/2, Eps15,AP-2, and Eps15,
Fcho1/2,AP-2 nanoclusters. Because of the
higher apparent affinity of the Fcho mHD for the
DPFs in Eps15/R, formation of Eps15,Fcho1/2 will
be favored at inchoate sites of CCS assembly.
(C–E) Representative deep-etch electron micro-
scopic image views of adherent ventral cell mem-
branes of HeLa SS6 cells immunogold labeled for
FCHO2with 18 nm colloidal gold (arrows). Proteins
assembled around the perimeter (chartreuse) of
characteristic polyhedrally assembled clathrin lat-
tice (purple) are pseudo-colored (C). Scale bar,
100 nm.transferrin internalization in confocal image stacks that were collected
following the pulse-chase format was analyzed using Fiji software (Schindelin
et al., 2012). Images were corrected for the background. A 10.09 3 10.09-mm
area was selected as a region of interest (ROI) in basal, middle, and upper sec-
tions of each cell in the z stack. Each optical section image was saved and pro-cessed separately. A mask for each image was created by applying a manual
threshold. The mask was then used on the corresponding ROI image to mea-
sure the number and intensity of each spot in different cells. For cells in the
different populations (control untransfected, Tac-mHD, or Tac-linker express-
ing), the intensity values of spots in each population set were pooled togetherDevelopmental Cell 37, 428–443, June 6, 2016 441
and plotted in the histogram with the same total area (2,443.4 mm2) for
comparison.Live-Cell Imaging
Starved cells in glass-bottomed MatTek dishes were imaged by TIRFM. Four
separate positions were selected for each experiment and images were
collected every 5 s for 5 min. The surface residence times of positively labeled
structures were calculated using Imaris (Bitplane). The ‘‘spots’’ function was
used to delineate AP-2 (b2-YFP)-positive structures in selected ROIs using
local contrast thresholding of the TIRFM datasets. Spots were uniformly sized
at slightly greater than diffraction limit (267 nm) for the 100 3 1.49 NA TIRFM
objective and the wavelength of light collected. Spot persistence was tracked
over time (5 s image separation) to determine duration of residency of individ-
ual structures at the cell surface. In addition, live-cell TIRFM images and immu-
nofluorescence confocal images from fixed cells were analyzed by using Fiji
and MetaMorph. Raw AP-2 channel images were background corrected.
For AP-2 TIRFM datasets, 2D deconvolution was then applied to these images
in MetaMorph to increase the signal-to-noise ratio. Further analysis was car-
ried out using Fiji; individual cells were marked and saved separately. Decon-
voluted images were smoothed and thresholded manually to create a mask,
and masks used on the corresponding background-corrected images to
calculate values for the size/area of the AP-2 puncta.ACCESSION NUMBERS
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